X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (31) 31
humans (31) 31
oncology (23) 23
adult (22) 22
middle aged (19) 19
chemotherapy (18) 18
index medicus (18) 18
breast cancer (17) 17
aged (15) 15
breast neoplasms - drug therapy (11) 11
prognosis (11) 11
cancer (10) 10
obstetrics & gynecology (10) 10
pregnancy (10) 10
metastasis (9) 9
health aspects (8) 8
retrospective studies (8) 8
survival (8) 8
therapy (8) 8
breast neoplasms - pathology (7) 7
medicine & public health (7) 7
ovarian cancer (7) 7
cancer therapies (6) 6
disease-free survival (6) 6
management (6) 6
survival analysis (6) 6
treatment outcome (6) 6
aged, 80 and over (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
breast neoplasms - mortality (5) 5
carcinoma (5) 5
neoplasm staging (5) 5
ovarian neoplasms - pathology (5) 5
time factors (5) 5
care and treatment (4) 4
chemotherapy, adjuvant (4) 4
follow-up studies (4) 4
gynecology (4) 4
impact (4) 4
kaplan-meier estimate (4) 4
lymphadenectomy (4) 4
lymphatic metastasis (4) 4
node metastases (4) 4
paclitaxel (4) 4
patients (4) 4
receptor, erbb-2 - metabolism (4) 4
recurrence (4) 4
risk assessment (4) 4
risk factors (4) 4
surgery (4) 4
trastuzumab (4) 4
trial (4) 4
womens health (4) 4
advanced ovarian cancer (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - surgery (3) 3
breast neoplasms - therapy (3) 3
combined modality therapy (3) 3
double-blind method (3) 3
drug administration schedule (3) 3
efficacy (3) 3
erbb-2 protein (3) 3
estrogen (3) 3
hematology (3) 3
infant, newborn (3) 3
internal medicine (3) 3
metastases (3) 3
mortality (3) 3
neoplasm recurrence, local - pathology (3) 3
neutropenia (3) 3
node ratio (3) 3
ovarian neoplasms - mortality (3) 3
ovarian neoplasms - surgery (3) 3
pertuzumab (3) 3
pharmaforum (3) 3
pregnancy trimester, second (3) 3
prospective studies (3) 3
reproductive biology (3) 3
research (3) 3
safety (3) 3
10-years follow-up (2) 2
abdominal surgery (2) 2
adjuvant (2) 2
adjuvant treatment (2) 2
adolescent (2) 2
aminopyridines - administration & dosage (2) 2
animals (2) 2
anthracycline (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
birth weight (2) 2
bleomycin (2) 2
breast neoplasms (2) 2
breast neoplasms - enzymology (2) 2
breast neoplasms - genetics (2) 2
cancer research (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Tumor Diagnostik und Therapie, ISSN 0722-219X, 2017, Volume 38, Issue 4, pp. 235 - 238
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e17549 - e17549
Journal Article
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2019, Volume 25, Issue 9, pp. 2717 - 2724
Purpose: To assess talazoparib activity in germline BRCA1/2 mutation carriers with advanced breast cancer. Patients and Methods: ABRAZO (NCT02034916) was a... 
TRIAL | OLAPARIB | RIBOSE POLYMERASE INHIBITORS | THERAPY | ONCOLOGY | SAFETY | DNA | ADVANCED OVARIAN | PARP | CARRIERS
Journal Article
Journal Article
Onkologische Welt, ISSN 1869-0874, 04/2012, Volume 3, Issue 4, pp. 175 - 176
Besonders beim metastasierten Mammakarzinom ist das Therapieziel neben der Lebensverlängerung stets der Erhalt einer guten Lebensqualität. Praxiserfahrungen... 
Forum Mamma-Karzinom
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2018, Volume 110, Issue 6, pp. 628 - 637
Pathological complete response (pCR) is associated with improved prognosis in triple-negative breast cancer (TNBC). The optimal chemotherapy regimen is... 
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 8/2015, Volume 141, Issue 8, pp. 1475 - 1480
To delineate the relevance of pelvic and para-aortic node involvement in optimally cytoreduced (residual tumour <1 cm) stage IIIC ovarian cancer... 
Lymphadenectomy | Prognosis | Node metastases | Medicine & Public Health | Hematology | Oncology | Cancer Research | Internal Medicine | Node ratio | Tumour | Advanced ovarian cancer | Residual | Chemotherapy | Metastasis | Health aspects | Ovarian cancer | Cancer
Journal Article
Journal Article